Pharmaceutical Research Scientist vs Regulatory Affairs Executive: which career is safer from AI?
Pharmaceutical Research Scientist is the safer bet: future safety 62/100 against 55/100 for Regulatory Affairs Executive.
| Pharmaceutical Research Scientist | Regulatory Affairs Executive | |
|---|---|---|
| AI risk by 2035 | 38/100 | 50/100 |
| Future safety | 62/100 | 55/100 |
| Jobs in India | Demand steady | Demand steady |
| Starting salary | ₹3 - ₹5 Lakh/annum | ₹3 - ₹5 Lakh/annum |
| First to go to AI | Running routine analytical tests on samples using HPLC, GC and mass spectrometry | Compiling and checking approval dossiers for new drugs, generics and formulation changes |
| Verdict | Safe if you own the bench: AI will design molecules faster, but someone still has to run the experiment. | Safe if you move into strategy and export work: AI is taking the dossier assembly and checking, not the filing judgment. |
| Salary in 2035 | ₹00 - ₹00 Lakh | ₹00 - ₹00 Lakh |
Unlock both full reports free
Free, takes 30 seconds. Already have an account? Log in
Will AI replace Pharmaceutical Research Scientist? Full outlook →Will AI replace Regulatory Affairs Executive? Full outlook →
Still stuck between Pharmaceutical Research Scientist and Regulatory Affairs Executive?
Two good careers can be a bad fit for the same person. The career test compares both against your interests, aptitude and personality, and a counsellor helps you decide.